Global Chronic Urticaria Or Hives Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Chronic Urticaria Or Hives Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Chronic Urticaria Or Hives Drug industry chain, the market status of Clinic (GDC-0853, GSK-2646264), Hospital (GDC-0853, GSK-2646264), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Chronic Urticaria Or Hives Drug.
Regionally, the report analyzes the Chronic Urticaria Or Hives Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Chronic Urticaria Or Hives Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Chronic Urticaria Or Hives Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Chronic Urticaria Or Hives Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., GDC-0853, GSK-2646264).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Chronic Urticaria Or Hives Drug market.
Regional Analysis: The report involves examining the Chronic Urticaria Or Hives Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Chronic Urticaria Or Hives Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Chronic Urticaria Or Hives Drug:
Company Analysis: Report covers individual Chronic Urticaria Or Hives Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Chronic Urticaria Or Hives Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinic, Hospital).
Technology Analysis: Report covers specific technologies relevant to Chronic Urticaria Or Hives Drug. It assesses the current state, advancements, and potential future developments in Chronic Urticaria Or Hives Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Chronic Urticaria Or Hives Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Chronic Urticaria Or Hives Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Chronic Urticaria Or Hives Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chronic Urticaria Or Hives Drug, with price, sales, revenue and global market share of Chronic Urticaria Or Hives Drug from 2019 to 2024.
Chapter 3, the Chronic Urticaria Or Hives Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Urticaria Or Hives Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Chronic Urticaria Or Hives Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Urticaria Or Hives Drug.
Chapter 14 and 15, to describe Chronic Urticaria Or Hives Drug sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Chronic Urticaria Or Hives Drug industry chain, the market status of Clinic (GDC-0853, GSK-2646264), Hospital (GDC-0853, GSK-2646264), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Chronic Urticaria Or Hives Drug.
Regionally, the report analyzes the Chronic Urticaria Or Hives Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Chronic Urticaria Or Hives Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Chronic Urticaria Or Hives Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Chronic Urticaria Or Hives Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., GDC-0853, GSK-2646264).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Chronic Urticaria Or Hives Drug market.
Regional Analysis: The report involves examining the Chronic Urticaria Or Hives Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Chronic Urticaria Or Hives Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Chronic Urticaria Or Hives Drug:
Company Analysis: Report covers individual Chronic Urticaria Or Hives Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Chronic Urticaria Or Hives Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinic, Hospital).
Technology Analysis: Report covers specific technologies relevant to Chronic Urticaria Or Hives Drug. It assesses the current state, advancements, and potential future developments in Chronic Urticaria Or Hives Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Chronic Urticaria Or Hives Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Chronic Urticaria Or Hives Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- GDC-0853
- GSK-2646264
- BF-Derm-1
- Bilastine
- Others
- Clinic
- Hospital
- Others
- AstraZeneca Plc
- Biofrontera AG
- ELORAC, Inc.
- Faes Farma, SA
- Genentech, Inc.
- GlaxoSmithKline Plc
- J Uriach Y Compania, S.A.
- Mabtech Limited
- Merck & Co., Inc.
- Mycenax Biotech Inc.
- Novartis AG
- Panacea Biotec Limited
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Chronic Urticaria Or Hives Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chronic Urticaria Or Hives Drug, with price, sales, revenue and global market share of Chronic Urticaria Or Hives Drug from 2019 to 2024.
Chapter 3, the Chronic Urticaria Or Hives Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Urticaria Or Hives Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Chronic Urticaria Or Hives Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Urticaria Or Hives Drug.
Chapter 14 and 15, to describe Chronic Urticaria Or Hives Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Chronic Urticaria Or Hives Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Chronic Urticaria Or Hives Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 GDC-0853
1.3.3 GSK-2646264
1.3.4 BF-Derm-1
1.3.5 Bilastine
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Chronic Urticaria Or Hives Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global Chronic Urticaria Or Hives Drug Market Size & Forecast
1.5.1 Global Chronic Urticaria Or Hives Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Chronic Urticaria Or Hives Drug Sales Quantity (2019-2030)
1.5.3 Global Chronic Urticaria Or Hives Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business
2.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Services
2.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Plc Recent Developments/Updates
2.2 Biofrontera AG
2.2.1 Biofrontera AG Details
2.2.2 Biofrontera AG Major Business
2.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Product and Services
2.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biofrontera AG Recent Developments/Updates
2.3 ELORAC, Inc.
2.3.1 ELORAC, Inc. Details
2.3.2 ELORAC, Inc. Major Business
2.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product and Services
2.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ELORAC, Inc. Recent Developments/Updates
2.4 Faes Farma, SA
2.4.1 Faes Farma, SA Details
2.4.2 Faes Farma, SA Major Business
2.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Services
2.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Faes Farma, SA Recent Developments/Updates
2.5 Genentech, Inc.
2.5.1 Genentech, Inc. Details
2.5.2 Genentech, Inc. Major Business
2.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Product and Services
2.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Genentech, Inc. Recent Developments/Updates
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Services
2.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Plc Recent Developments/Updates
2.7 J Uriach Y Compania, S.A.
2.7.1 J Uriach Y Compania, S.A. Details
2.7.2 J Uriach Y Compania, S.A. Major Business
2.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product and Services
2.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 J Uriach Y Compania, S.A. Recent Developments/Updates
2.8 Mabtech Limited
2.8.1 Mabtech Limited Details
2.8.2 Mabtech Limited Major Business
2.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Product and Services
2.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mabtech Limited Recent Developments/Updates
2.9 Merck & Co., Inc.
2.9.1 Merck & Co., Inc. Details
2.9.2 Merck & Co., Inc. Major Business
2.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product and Services
2.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck & Co., Inc. Recent Developments/Updates
2.10 Mycenax Biotech Inc.
2.10.1 Mycenax Biotech Inc. Details
2.10.2 Mycenax Biotech Inc. Major Business
2.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product and Services
2.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mycenax Biotech Inc. Recent Developments/Updates
2.11 Novartis AG
2.11.1 Novartis AG Details
2.11.2 Novartis AG Major Business
2.11.3 Novartis AG Chronic Urticaria Or Hives Drug Product and Services
2.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Novartis AG Recent Developments/Updates
2.12 Panacea Biotec Limited
2.12.1 Panacea Biotec Limited Details
2.12.2 Panacea Biotec Limited Major Business
2.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Services
2.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Panacea Biotec Limited Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHRONIC URTICARIA OR HIVES DRUG BY MANUFACTURER
3.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2019-2024)
3.3 Global Chronic Urticaria Or Hives Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Chronic Urticaria Or Hives Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Chronic Urticaria Or Hives Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Chronic Urticaria Or Hives Drug Manufacturer Market Share in 2023
3.5 Chronic Urticaria Or Hives Drug Market: Overall Company Footprint Analysis
3.5.1 Chronic Urticaria Or Hives Drug Market: Region Footprint
3.5.2 Chronic Urticaria Or Hives Drug Market: Company Product Type Footprint
3.5.3 Chronic Urticaria Or Hives Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Chronic Urticaria Or Hives Drug Market Size by Region
4.1.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2030)
4.1.3 Global Chronic Urticaria Or Hives Drug Average Price by Region (2019-2030)
4.2 North America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.3 Europe Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.5 South America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
5.2 Global Chronic Urticaria Or Hives Drug Consumption Value by Type (2019-2030)
5.3 Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
6.2 Global Chronic Urticaria Or Hives Drug Consumption Value by Application (2019-2030)
6.3 Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
7.2 North America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
7.3 North America Chronic Urticaria Or Hives Drug Market Size by Country
7.3.1 North America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
8.2 Europe Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
8.3 Europe Chronic Urticaria Or Hives Drug Market Size by Country
8.3.1 Europe Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Region
9.3.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
10.2 South America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
10.3 South America Chronic Urticaria Or Hives Drug Market Size by Country
10.3.1 South America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Chronic Urticaria Or Hives Drug Market Size by Country
11.3.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Chronic Urticaria Or Hives Drug Market Drivers
12.2 Chronic Urticaria Or Hives Drug Market Restraints
12.3 Chronic Urticaria Or Hives Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Chronic Urticaria Or Hives Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chronic Urticaria Or Hives Drug
13.3 Chronic Urticaria Or Hives Drug Production Process
13.4 Chronic Urticaria Or Hives Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chronic Urticaria Or Hives Drug Typical Distributors
14.3 Chronic Urticaria Or Hives Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Chronic Urticaria Or Hives Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Chronic Urticaria Or Hives Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 GDC-0853
1.3.3 GSK-2646264
1.3.4 BF-Derm-1
1.3.5 Bilastine
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Chronic Urticaria Or Hives Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global Chronic Urticaria Or Hives Drug Market Size & Forecast
1.5.1 Global Chronic Urticaria Or Hives Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Chronic Urticaria Or Hives Drug Sales Quantity (2019-2030)
1.5.3 Global Chronic Urticaria Or Hives Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business
2.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Services
2.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Plc Recent Developments/Updates
2.2 Biofrontera AG
2.2.1 Biofrontera AG Details
2.2.2 Biofrontera AG Major Business
2.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Product and Services
2.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biofrontera AG Recent Developments/Updates
2.3 ELORAC, Inc.
2.3.1 ELORAC, Inc. Details
2.3.2 ELORAC, Inc. Major Business
2.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product and Services
2.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ELORAC, Inc. Recent Developments/Updates
2.4 Faes Farma, SA
2.4.1 Faes Farma, SA Details
2.4.2 Faes Farma, SA Major Business
2.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Services
2.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Faes Farma, SA Recent Developments/Updates
2.5 Genentech, Inc.
2.5.1 Genentech, Inc. Details
2.5.2 Genentech, Inc. Major Business
2.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Product and Services
2.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Genentech, Inc. Recent Developments/Updates
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Services
2.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Plc Recent Developments/Updates
2.7 J Uriach Y Compania, S.A.
2.7.1 J Uriach Y Compania, S.A. Details
2.7.2 J Uriach Y Compania, S.A. Major Business
2.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product and Services
2.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 J Uriach Y Compania, S.A. Recent Developments/Updates
2.8 Mabtech Limited
2.8.1 Mabtech Limited Details
2.8.2 Mabtech Limited Major Business
2.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Product and Services
2.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mabtech Limited Recent Developments/Updates
2.9 Merck & Co., Inc.
2.9.1 Merck & Co., Inc. Details
2.9.2 Merck & Co., Inc. Major Business
2.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product and Services
2.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck & Co., Inc. Recent Developments/Updates
2.10 Mycenax Biotech Inc.
2.10.1 Mycenax Biotech Inc. Details
2.10.2 Mycenax Biotech Inc. Major Business
2.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product and Services
2.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mycenax Biotech Inc. Recent Developments/Updates
2.11 Novartis AG
2.11.1 Novartis AG Details
2.11.2 Novartis AG Major Business
2.11.3 Novartis AG Chronic Urticaria Or Hives Drug Product and Services
2.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Novartis AG Recent Developments/Updates
2.12 Panacea Biotec Limited
2.12.1 Panacea Biotec Limited Details
2.12.2 Panacea Biotec Limited Major Business
2.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Services
2.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Panacea Biotec Limited Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHRONIC URTICARIA OR HIVES DRUG BY MANUFACTURER
3.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2019-2024)
3.3 Global Chronic Urticaria Or Hives Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Chronic Urticaria Or Hives Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Chronic Urticaria Or Hives Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Chronic Urticaria Or Hives Drug Manufacturer Market Share in 2023
3.5 Chronic Urticaria Or Hives Drug Market: Overall Company Footprint Analysis
3.5.1 Chronic Urticaria Or Hives Drug Market: Region Footprint
3.5.2 Chronic Urticaria Or Hives Drug Market: Company Product Type Footprint
3.5.3 Chronic Urticaria Or Hives Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Chronic Urticaria Or Hives Drug Market Size by Region
4.1.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2030)
4.1.3 Global Chronic Urticaria Or Hives Drug Average Price by Region (2019-2030)
4.2 North America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.3 Europe Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.5 South America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Chronic Urticaria Or Hives Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
5.2 Global Chronic Urticaria Or Hives Drug Consumption Value by Type (2019-2030)
5.3 Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
6.2 Global Chronic Urticaria Or Hives Drug Consumption Value by Application (2019-2030)
6.3 Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
7.2 North America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
7.3 North America Chronic Urticaria Or Hives Drug Market Size by Country
7.3.1 North America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
8.2 Europe Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
8.3 Europe Chronic Urticaria Or Hives Drug Market Size by Country
8.3.1 Europe Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Region
9.3.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
10.2 South America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
10.3 South America Chronic Urticaria Or Hives Drug Market Size by Country
10.3.1 South America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Chronic Urticaria Or Hives Drug Market Size by Country
11.3.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Chronic Urticaria Or Hives Drug Market Drivers
12.2 Chronic Urticaria Or Hives Drug Market Restraints
12.3 Chronic Urticaria Or Hives Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Chronic Urticaria Or Hives Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chronic Urticaria Or Hives Drug
13.3 Chronic Urticaria Or Hives Drug Production Process
13.4 Chronic Urticaria Or Hives Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chronic Urticaria Or Hives Drug Typical Distributors
14.3 Chronic Urticaria Or Hives Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Chronic Urticaria Or Hives Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Chronic Urticaria Or Hives Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Plc Major Business
Table 5. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Services
Table 6. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. AstraZeneca Plc Recent Developments/Updates
Table 8. Biofrontera AG Basic Information, Manufacturing Base and Competitors
Table 9. Biofrontera AG Major Business
Table 10. Biofrontera AG Chronic Urticaria Or Hives Drug Product and Services
Table 11. Biofrontera AG Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biofrontera AG Recent Developments/Updates
Table 13. ELORAC, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. ELORAC, Inc. Major Business
Table 15. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 16. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. ELORAC, Inc. Recent Developments/Updates
Table 18. Faes Farma, SA Basic Information, Manufacturing Base and Competitors
Table 19. Faes Farma, SA Major Business
Table 20. Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Services
Table 21. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Faes Farma, SA Recent Developments/Updates
Table 23. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Genentech, Inc. Major Business
Table 25. Genentech, Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 26. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Genentech, Inc. Recent Developments/Updates
Table 28. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Plc Major Business
Table 30. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Services
Table 31. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Plc Recent Developments/Updates
Table 33. J Uriach Y Compania, S.A. Basic Information, Manufacturing Base and Competitors
Table 34. J Uriach Y Compania, S.A. Major Business
Table 35. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product and Services
Table 36. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. J Uriach Y Compania, S.A. Recent Developments/Updates
Table 38. Mabtech Limited Basic Information, Manufacturing Base and Competitors
Table 39. Mabtech Limited Major Business
Table 40. Mabtech Limited Chronic Urticaria Or Hives Drug Product and Services
Table 41. Mabtech Limited Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mabtech Limited Recent Developments/Updates
Table 43. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co., Inc. Major Business
Table 45. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 46. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Merck & Co., Inc. Recent Developments/Updates
Table 48. Mycenax Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Mycenax Biotech Inc. Major Business
Table 50. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 51. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Mycenax Biotech Inc. Recent Developments/Updates
Table 53. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 54. Novartis AG Major Business
Table 55. Novartis AG Chronic Urticaria Or Hives Drug Product and Services
Table 56. Novartis AG Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Novartis AG Recent Developments/Updates
Table 58. Panacea Biotec Limited Basic Information, Manufacturing Base and Competitors
Table 59. Panacea Biotec Limited Major Business
Table 60. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Services
Table 61. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Panacea Biotec Limited Recent Developments/Updates
Table 63. Global Chronic Urticaria Or Hives Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 64. Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Chronic Urticaria Or Hives Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 66. Market Position of Manufacturers in Chronic Urticaria Or Hives Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Chronic Urticaria Or Hives Drug Production Site of Key Manufacturer
Table 68. Chronic Urticaria Or Hives Drug Market: Company Product Type Footprint
Table 69. Chronic Urticaria Or Hives Drug Market: Company Product Application Footprint
Table 70. Chronic Urticaria Or Hives Drug New Market Entrants and Barriers to Market Entry
Table 71. Chronic Urticaria Or Hives Drug Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 73. Global Chronic Urticaria Or Hives Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 74. Global Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Chronic Urticaria Or Hives Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Chronic Urticaria Or Hives Drug Average Price by Region (2019-2024) & (USD/Pcs)
Table 77. Global Chronic Urticaria Or Hives Drug Average Price by Region (2025-2030) & (USD/Pcs)
Table 78. Global Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 79. Global Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 80. Global Chronic Urticaria Or Hives Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Chronic Urticaria Or Hives Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2024) & (USD/Pcs)
Table 83. Global Chronic Urticaria Or Hives Drug Average Price by Type (2025-2030) & (USD/Pcs)
Table 84. Global Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 85. Global Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 86. Global Chronic Urticaria Or Hives Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Chronic Urticaria Or Hives Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2024) & (USD/Pcs)
Table 89. Global Chronic Urticaria Or Hives Drug Average Price by Application (2025-2030) & (USD/Pcs)
Table 90. North America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 91. North America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 92. North America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 93. North America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 94. North America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 95. North America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 96. North America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Chronic Urticaria Or Hives Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 99. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 100. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 101. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 102. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 103. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 104. Europe Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Chronic Urticaria Or Hives Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 107. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 108. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 109. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 110. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 111. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 112. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 115. South America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 116. South America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 117. South America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 118. South America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 119. South America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 120. South America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Chronic Urticaria Or Hives Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 123. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 124. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 125. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 126. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 127. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 128. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Chronic Urticaria Or Hives Drug Raw Material
Table 131. Key Manufacturers of Chronic Urticaria Or Hives Drug Raw Materials
Table 132. Chronic Urticaria Or Hives Drug Typical Distributors
Table 133. Chronic Urticaria Or Hives Drug Typical Customers
Table 1. Global Chronic Urticaria Or Hives Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Chronic Urticaria Or Hives Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Plc Major Business
Table 5. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Services
Table 6. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. AstraZeneca Plc Recent Developments/Updates
Table 8. Biofrontera AG Basic Information, Manufacturing Base and Competitors
Table 9. Biofrontera AG Major Business
Table 10. Biofrontera AG Chronic Urticaria Or Hives Drug Product and Services
Table 11. Biofrontera AG Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biofrontera AG Recent Developments/Updates
Table 13. ELORAC, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. ELORAC, Inc. Major Business
Table 15. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 16. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. ELORAC, Inc. Recent Developments/Updates
Table 18. Faes Farma, SA Basic Information, Manufacturing Base and Competitors
Table 19. Faes Farma, SA Major Business
Table 20. Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Services
Table 21. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Faes Farma, SA Recent Developments/Updates
Table 23. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Genentech, Inc. Major Business
Table 25. Genentech, Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 26. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Genentech, Inc. Recent Developments/Updates
Table 28. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Plc Major Business
Table 30. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Services
Table 31. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Plc Recent Developments/Updates
Table 33. J Uriach Y Compania, S.A. Basic Information, Manufacturing Base and Competitors
Table 34. J Uriach Y Compania, S.A. Major Business
Table 35. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product and Services
Table 36. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. J Uriach Y Compania, S.A. Recent Developments/Updates
Table 38. Mabtech Limited Basic Information, Manufacturing Base and Competitors
Table 39. Mabtech Limited Major Business
Table 40. Mabtech Limited Chronic Urticaria Or Hives Drug Product and Services
Table 41. Mabtech Limited Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mabtech Limited Recent Developments/Updates
Table 43. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co., Inc. Major Business
Table 45. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 46. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Merck & Co., Inc. Recent Developments/Updates
Table 48. Mycenax Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Mycenax Biotech Inc. Major Business
Table 50. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 51. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Mycenax Biotech Inc. Recent Developments/Updates
Table 53. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 54. Novartis AG Major Business
Table 55. Novartis AG Chronic Urticaria Or Hives Drug Product and Services
Table 56. Novartis AG Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Novartis AG Recent Developments/Updates
Table 58. Panacea Biotec Limited Basic Information, Manufacturing Base and Competitors
Table 59. Panacea Biotec Limited Major Business
Table 60. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Services
Table 61. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Panacea Biotec Limited Recent Developments/Updates
Table 63. Global Chronic Urticaria Or Hives Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 64. Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Chronic Urticaria Or Hives Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 66. Market Position of Manufacturers in Chronic Urticaria Or Hives Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Chronic Urticaria Or Hives Drug Production Site of Key Manufacturer
Table 68. Chronic Urticaria Or Hives Drug Market: Company Product Type Footprint
Table 69. Chronic Urticaria Or Hives Drug Market: Company Product Application Footprint
Table 70. Chronic Urticaria Or Hives Drug New Market Entrants and Barriers to Market Entry
Table 71. Chronic Urticaria Or Hives Drug Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 73. Global Chronic Urticaria Or Hives Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 74. Global Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Chronic Urticaria Or Hives Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Chronic Urticaria Or Hives Drug Average Price by Region (2019-2024) & (USD/Pcs)
Table 77. Global Chronic Urticaria Or Hives Drug Average Price by Region (2025-2030) & (USD/Pcs)
Table 78. Global Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 79. Global Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 80. Global Chronic Urticaria Or Hives Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Chronic Urticaria Or Hives Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2024) & (USD/Pcs)
Table 83. Global Chronic Urticaria Or Hives Drug Average Price by Type (2025-2030) & (USD/Pcs)
Table 84. Global Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 85. Global Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 86. Global Chronic Urticaria Or Hives Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Chronic Urticaria Or Hives Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2024) & (USD/Pcs)
Table 89. Global Chronic Urticaria Or Hives Drug Average Price by Application (2025-2030) & (USD/Pcs)
Table 90. North America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 91. North America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 92. North America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 93. North America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 94. North America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 95. North America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 96. North America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Chronic Urticaria Or Hives Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 99. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 100. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 101. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 102. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 103. Europe Chronic Urticaria Or Hives Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 104. Europe Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Chronic Urticaria Or Hives Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 107. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 108. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 109. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 110. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 111. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 112. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 115. South America Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 116. South America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 117. South America Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 118. South America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 119. South America Chronic Urticaria Or Hives Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 120. South America Chronic Urticaria Or Hives Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Chronic Urticaria Or Hives Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 123. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 124. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 125. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 126. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 127. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 128. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Chronic Urticaria Or Hives Drug Raw Material
Table 131. Key Manufacturers of Chronic Urticaria Or Hives Drug Raw Materials
Table 132. Chronic Urticaria Or Hives Drug Typical Distributors
Table 133. Chronic Urticaria Or Hives Drug Typical Customers
LIST OF FIGURES
Figure 1. Chronic Urticaria Or Hives Drug Picture
Figure 2. Global Chronic Urticaria Or Hives Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Type in 2023
Figure 4. GDC-0853 Examples
Figure 5. GSK-2646264 Examples
Figure 6. BF-Derm-1 Examples
Figure 7. Bilastine Examples
Figure 8. Others Examples
Figure 9. Global Chronic Urticaria Or Hives Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Application in 2023
Figure 11. Clinic Examples
Figure 12. Hospital Examples
Figure 13. Others Examples
Figure 14. Global Chronic Urticaria Or Hives Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Chronic Urticaria Or Hives Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Chronic Urticaria Or Hives Drug Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global Chronic Urticaria Or Hives Drug Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Chronic Urticaria Or Hives Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Chronic Urticaria Or Hives Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Chronic Urticaria Or Hives Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Chronic Urticaria Or Hives Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Chronic Urticaria Or Hives Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Chronic Urticaria Or Hives Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Chronic Urticaria Or Hives Drug Market Drivers
Figure 77. Chronic Urticaria Or Hives Drug Market Restraints
Figure 78. Chronic Urticaria Or Hives Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug in 2023
Figure 81. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure 82. Chronic Urticaria Or Hives Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Chronic Urticaria Or Hives Drug Picture
Figure 2. Global Chronic Urticaria Or Hives Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Type in 2023
Figure 4. GDC-0853 Examples
Figure 5. GSK-2646264 Examples
Figure 6. BF-Derm-1 Examples
Figure 7. Bilastine Examples
Figure 8. Others Examples
Figure 9. Global Chronic Urticaria Or Hives Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Application in 2023
Figure 11. Clinic Examples
Figure 12. Hospital Examples
Figure 13. Others Examples
Figure 14. Global Chronic Urticaria Or Hives Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Chronic Urticaria Or Hives Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Chronic Urticaria Or Hives Drug Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global Chronic Urticaria Or Hives Drug Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Chronic Urticaria Or Hives Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Chronic Urticaria Or Hives Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Chronic Urticaria Or Hives Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Chronic Urticaria Or Hives Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Chronic Urticaria Or Hives Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Chronic Urticaria Or Hives Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Chronic Urticaria Or Hives Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Chronic Urticaria Or Hives Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Chronic Urticaria Or Hives Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Chronic Urticaria Or Hives Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Chronic Urticaria Or Hives Drug Market Drivers
Figure 77. Chronic Urticaria Or Hives Drug Market Restraints
Figure 78. Chronic Urticaria Or Hives Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug in 2023
Figure 81. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure 82. Chronic Urticaria Or Hives Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
